Drug General Information
Drug ID	D0M2GI
Former ID	DIB016636
Drug Name	CI-1002
Synonyms	PD-142676
Indication	Alzheimer disease [ICD9: 331; ICD10:G30]		Terminated	[533784]
Company	Parke-Davis & Co
Structure		Download 2D MOL 3D MOL
Canonical SMILES	N1=C2N(Cc3c1cc(cc3Cl)Cl)CCCCC2
CAS Number	CAS 149028-28-4
Target and Pathway
Target(s)	Acetylcholinesterase	Target Info	Modulator	[533784]
KEGG Pathway	Glycerophospholipid metabolism
	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer Pathway
References
Ref 533784	PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonist. Mol Neurobiol. 1994 Aug-Dec;9(1-3):93-106.
Ref 533784	PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonist. Mol Neurobiol. 1994 Aug-Dec;9(1-3):93-106.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.